Storskogen Group Valuation

Is 0VK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0VK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0VK (€0.8) is trading below our estimate of fair value (€2.69)

Significantly Below Fair Value: 0VK is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0VK?

Key metric: As 0VK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0VK. This is calculated by dividing 0VK's market cap by their current revenue.
What is 0VK's PS Ratio?
PS Ratio0.5x
SalesSEK 34.59b
Market CapSEK 16.19b

Price to Sales Ratio vs Peers

How does 0VK's PS Ratio compare to its peers?

The above table shows the PS ratio for 0VK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
MBB MBB
0.5x6.5%€559.9m
INH INDUS Holding
0.3x3.7%€548.2m
IUR KAP
0.3xn/a€77.7m
UUU 3U Holding
1x9.2%€55.7m
0VK Storskogen Group
0.5x1.4%€16.2b

Price-To-Sales vs Peers: 0VK is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does 0VK's PS Ratio compare vs other companies in the European Industrials Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
0VK 0.5xIndustry Avg. 0.9xNo. of Companies7PS00.81.62.43.24+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0VK is good value based on its Price-To-Sales Ratio (0.5x) compared to the European Industrials industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is 0VK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0VK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: 0VK is expensive based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0VK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.80
€1.20
+49.4%
22.0%€1.56€0.91n/a5
Nov ’25€0.76
€1.14
+50.9%
24.0%€1.55€0.82n/a5
Oct ’25€0.85
€1.14
+33.0%
30.4%€1.66€0.70n/a5
Sep ’25€0.92
€1.11
+21.3%
29.8%€1.65€0.69n/a5
Aug ’25€0.75
€1.03
+37.2%
31.0%€1.48€0.61n/a5
Jul ’25€0.72
€1.03
+42.5%
31.0%€1.48€0.61n/a5
Jun ’25€0.68
€1.03
+51.9%
31.0%€1.48€0.61n/a5
May ’25€0.52
€0.94
+81.4%
43.7%€1.52€0.54n/a5
Apr ’25€0.49
€0.94
+93.2%
43.7%€1.52€0.54n/a5
Mar ’25€0.46
€0.98
+112.6%
46.1%€1.52€0.54n/a5
Feb ’25€0.64
€1.11
+72.5%
32.0%€1.58€0.75n/a5
Jan ’25€0.84
€1.23
+45.4%
23.0%€1.56€0.87n/a5
Dec ’24€0.67
€1.23
+82.9%
23.0%€1.56€0.87n/a5
Nov ’24€0.55
€1.21
+120.8%
22.8%€1.61€0.85€0.765
Oct ’24€0.66
€1.22
+84.8%
23.4%€1.61€0.85€0.855
Sep ’24€0.69
€1.22
+77.8%
23.4%€1.61€0.85€0.925
Aug ’24€0.93
€1.39
+49.4%
24.5%€2.00€0.95€0.756
Jul ’24€0.80
€1.39
+72.8%
24.5%€2.00€0.95€0.726
Jun ’24€1.01
€1.39
+37.6%
24.5%€2.00€0.95€0.686
May ’24€0.82
€1.36
+65.8%
22.1%€1.81€0.99€0.526
Apr ’24€0.71
€1.36
+90.5%
22.1%€1.81€0.99€0.496
Mar ’24€0.86
€1.36
+57.7%
22.1%€1.81€0.99€0.466
Feb ’24€0.77
€1.33
+72.9%
23.2%€1.82€0.91€0.646
Jan ’24€0.65
€1.33
+104.5%
23.2%€1.82€0.91€0.846
Dec ’23€0.70
€1.33
+89.2%
23.2%€1.82€0.91€0.676
Nov ’23€0.71
€1.70
+138.0%
33.7%€2.72€1.00€0.556

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies